Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis

References

• Chetter IC, Kent PJ, Kester RC. The hand arm vibration syndrome: a review. Cardiovasc Surg 1998;6:1–9.
   Google Scholar
• Ho M, Belch JJ. Raynaud's phenomenon: state of the art 1998 [Review]. Scand J Rheumatol 1998;27:319–22.
   PubMed Web of Science ®Google Scholar
• Kallenberg CGM, Wouda AA, Hoet MH, Van Venrooij WJ. Development of connective tissue disease in patients present-ing with Raynaud's phenomenon: a six year follow-up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988;47:634–41.
   Google Scholar
• Maricq HR, Weinrich MC, Keil JE, Le Roy CE. Prevalence of Raynaud phenomenon in the general population. J Chron Dis 1986;39:423–7.
   Google Scholar
• Spencer-Green G. Outcomes in primary Raynaud phenom-enon. Arch Intern Med 1998;158:595–600.
   PubMedGoogle Scholar
• Gerbracht DD, Stehen VD, Ziegler DL, Medsger TA, Rodnan GP. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985; 28:87–92.
   Google Scholar
• Silveri F, De Angelis R, Poggi A, Muti S, Bonapace G, Argentati F, et al. Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis. Scand J Rheumatol 2001;30:290–6.
   PubMedGoogle Scholar
• Kallenberg CG, Wouda AA, The TH. Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med 1980;69:675–80.
   Google Scholar
• Mc Grath MA, Penny R. The mechanisms of Raynaud's phenomenon. Part 1. Med J Aust 1974;2:328–33.
   PubMedGoogle Scholar
• Fitzgerald O, Hess EV, O'Connor GT, Spencer-Green G. Prospective study of the evolution of Raynaud's phenomenon. Am J Med 1988;84:718–26.
   Google Scholar
• Landry GJ, Edwards JM, Mc Lafferty RB, Taylor LM, Porter JM. Long-term outcome of Raynaud's syndrome in a prospec-tively analyzed patient cohort. J Vasc Surg 1996;23:76–85.
   Google Scholar
• Luggen M, Belhom L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a long term prospective study. J Rheumatol 1995;22:2226–32.
   Google Scholar
• Boccalon HJ, Marguery MC, Ginestet MC, Puel PF. Laser Doppler flowmetry and standardized thermal test in normals and Raynaud's phenomenon. Int Angiol 1987;6:107–18.
   PubMedGoogle Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Subcommitee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315–24.
   Web of Science ®Google Scholar
• American College of Rheumatology ad hoc Committee on Clinical Guidelines. 1: Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. Arthritis Rheum 1996;39:1–8.
   PubMedGoogle Scholar
• Vitali C, Bombadieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific anti-body to an extractable nuclear antigen. Am J Med 1972;52:148–59.
   Google Scholar
• Appelboom T, Kahn MF, Mairesse N. Antibodies to small ribonucleoprotein and to 73-kD heat shock protein: two distinct markers of mixed connective tissue disease. Clin Exp Immunol 1995;100: 486–8.
   Google Scholar
• Beck JS. Variations in the morphological patterns of autoimmune nuclear fluorescence. Lancet 1961;1:1203.
   PubMedGoogle Scholar
• Aarden LA, De Groot CR, Feltkamp TEW. Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunfluorescence technique. Ann NY Acad Sci 1975;254:505.
   Google Scholar
• Hirschl M, Kundi M. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology. J Rheumatol 1996;23:302–9.
   PubMed Web of Science ®Google Scholar
• Lau CS, McLaren M, Saniabadi A, Belch JJ. Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis. Scand J Rheumatol 1993;22:97–101.
   PubMed Web of Science ®Google Scholar
• Gentric A, Blaschek MA, Le Noach JF, Johanet C, Jouquan J, Lamour A, et al. Serological arguments for classifying Raynaud's Phenomenon as idiopathic. J Rheumatol 1990; 17:1176–81.
   Google Scholar
• LeRoy EC, Medsger TA JR. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10: 485–8.
   PubMed Web of Science ®Google Scholar
• Kallenberg CG. Raynaud's phenomenon as an early sign of connective tissue disease. Vasa 1992;Suppl. 34:25–8.
   Google Scholar
• Bartelink ML, Wollersheim H, van de Lisdonk E, Thien T. Raynaud's phenomenon: subjective influence of female sex hormones. Int Angiol 1992;11:309–15.
   Google Scholar
• Harper FE, Maricq HR, Turner RE, Lidman RW, Leroy EC. A prospective study of Raynaud's phenomenon and early connective tissue disease. Am J Med 1982;72:883–8.
   Google Scholar